Clinical Trial Update: An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System [NA]

View source ↗

Summary

This open-label trial evaluating continuous use of the HemoCare Hemodialysis System in patients with end-stage renal disease has completed and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• HemoCare Hemodialysis System

Snippet

Sponsor: Deka Research and Development | Conditions: End Stage Renal Disease | NA | Status: COMPLETED | Results posted: 2025-09-08